We discuss the first interim results of a novel intravitreal gene therapy agent, 4D-150, with Dr. Arshad Khanani of Sierra Eye Associates and the University of Nevada Reno School of Medicine.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
